The matrix metalloproteinase (MMP) family (B25 members in mammals) has been implicated in extracellular matrix remodeling associated with embryonic development, cancer formation and progression, and various other physiological and pathological events. Inactivating mutations in individual matrix metalloproteinase genes in mice described so far, however, are nonlethal at least up to the first few weeks after birth, suggesting functional redundancy among MMP family members. Here, we report that mice lacking two MMPs, MMP-2 (nonmembrane type) and MT1-MMP (membrane type), die immediately after birth with respiratory failure, abnormal blood vessels, and immature muscle fibers reminiscent of central core disease. In the absence of MMP-2 and MT1-MMP, myoblast fusion in vitro is also significantly retarded. These findings suggest functional overlap in mice between the two MMPs with distinct molecular natures.
Introduction
Matrix metalloproteinases (MMPs) are a family of enzymes involved in extracellular matrix (ECM) remodeling and can be divided into two distinct subfamilies, membrane type and nonmembrane type (Vu and Werb, 2000; Egeblad and Werb, 2002) . Like many other extracellular proteases, MMPs are produced as inactive precursors; their NH 2 -terminal portion has to be removed to manifest the active enzymes (Nagase and Woessner, 1999) . One of the membrane type MMPs, named MT1-MMP, is known to be processed by a proprotein convertase, furin (Sato et al., 1996) , while a nonmembrane type MMP, named MMP-2, is activated in two steps, the first step mediated by MT1-MMP (Sato et al., 1994) and the second step by active MMP-2 (Atkinson et al., 1995) . Thus, it has been proposed that furin, MT1-MMP, and MMP-2 constitute a proteolytic cascade leading to ECM degradation in the pericellular space. Such model would predict that MT1-MMP and MMP-2 play distinct roles in this cascade and cannot functionally compensate each other.
Ample evidence suggests the involvement of MMPs in tumor invasion, metastasis, and angiogenesis (StetlerStevenson, 1999; Fang et al., 2000; Deryugina et al., 2002; Egeblad and Werb, 2002) . In addition, previous study indicated that the activity of MMP-2 and MT1-MMP is required for activity-induced angiogenesis in skeletal muscles of adult rats (Haas et al., 2000) . These and some other MMP family members have also been implicated in flow-mediated arterial enlargement (Karwowski et al., 1999; Tronc et al., 2000; de Kleijn et al., 2001; Sho et al., 2002) . However, although several mutant mice lacking individual MMPs have been generated (Itoh et al., 1997; Vu et al., 1998; Holmbeck et al., 1999) , no obvious defects in embryogenesis have been reported. In particular, mice lacking MMP-2 are healthy and fertile (Itoh et al., 1997 (Itoh et al., , 1998 . Newborn mice lacking MT1-MMP are indistinguishable from their wild-type or heterozygous littermates, although they exhibit skeletal defects and dwarfism, due to the inefficient vascular invasion into cartilage, within the first few weeks of postnatal life and eventually die (Holmbeck et al., 1999; Zhou et al., 2000) . Therefore, to unequivocally demonstrate the importance of these MMPs in normal development, mice lacking multiple MMPs would be imperative. Such studies would also shed lights on the functional relationships between MMPs during cancinogenesis.
Here, we report on the phenotype of mice carrying mutations in both MMP-2 and MT1-MMP genes. Our data indicate that inactivating mutations in the genes encoding these structurally distinct MMPs are synthetically lethal and that these enzymes play essential roles in vascular and skeletal muscle maturation during the embryogenesis.
Results

Perinatal death of MMP-2
To obtain mice lacking both MMP-2 and MT1-MMP, we first intercrossed MMP-2 À/À (henceforth referred to as M2
These double heterozygotes were then mated to obtain MMP-2 
MT
À neonates barely respond to external stimuli and appear to have difficulty in breathing -their lungs are not properly inflated (Figure 1b) . Their skulls and bones are generally smaller, and growth plate vascularization and ossification impaired (Figure 1c, d ). These skeletal phenotypes in the M2 À
À double mutants are reminiscent of those seen in MT À mice at much later stages (Holmbeck et al., 1999; Zhou et al., 2000) . Thus, the M2 À MT À double mutations gave rise to perinatal death accompanied by respiratory failure, which was not seen in either of the single mutants, as well as earlier manifestation of the skeletal phenotypes seen in the MT À single mutant mice. These results document a synthetic-lethal interaction between the two mutations and suggest functional redundancy between MMP-2 and MT1-MMP. neonates. This is in sharp contrast to the typical capillary vessels, with wide and smooth lumens and flattened cells (Figure 2d , left panel), found in the control animals. These findings suggest that proper vascular development, especially the formation of larger blood vessels and the attainment and/or maintenance of the proper caliber of capillary lumens, are compromised in the M2 À MT À mice. Despite these vascular abnormalities, the double mutant mice could survive their embryonic life, implying that their circulatory system is sufficiently functional at least during the embryogenesis. To determine the reason why the M2 À MT À neonates have difficulty in breathing, we examined their airways but found no evidence of physical blockade. Also, no obvious difference was found in the reaction of isolated diaphragms when their phrenic nerves were stimulated (not shown). We, however, consistently noticed the difference in the thickness of diaphragm (Figure 3a 
À neonates are either retarded or arrested at immature stages (for phenotypic changes observed during normal muscle maturation, see Furst et al., 1989) . However, no obvious difference was found in the cardiac muscles of the control M2 À and M2 Interestingly, the staining pattern for desmin in the M2 À MT À neonates resembles the pattern seen in a human congenital myopathy, central core disease (CCD) (Vita et al., 1994; van der Ven et al., 1995; Tubridy et al., 2001) . Moreover, the staining pattern for NADH-tetrazolium reductase (NADH-TR) (Figure 4c 
À neonates are all reminiscent of CCD (Tubridy et al., 2001) .
To address the question of whether the lack of functional MMP-2 and MT1-MMP affects skeletal muscle development directly or indirectly through the vascular defects, we performed two lines of experiments in tissue culture. First, we cultured cells from whole embryos at E10.5 on collagen-coated dishes. After 2-3 weeks, cells from wild-type embryos gave rise to clusters of string-like structures interspaced among various other types of colonies. These string-like structures were proven to be myotubes by their multinucleated morphology ( Figure 6a ) and electrophysiological properties (data not shown). Although this experimental system is crude and may produce large variation, we consistently observed much less number of myotubes formed when cells from M2 À
À embryos were cultured (Figure 6b ), suggesting that MMP-2 and MT1-MMP are important for the efficient myotube formation under these conditions.
In another in vitro experiment, we examined the effects of the overexpression of MMP-2 and MT1-MMP on myotube formation in the myogenic C2C12 cell line (Figure 7a ). When the expression of either MMP-2 or MT1-MMP alone was elevated, myotube formation was reduced as compared to the vector-transfected control cells. However, the overexpression of both MMP-2 and MT1-MMP augmented myotube formation considerably (Figure 7b, c) . These findings further support the positive and cooperative roles of MMP-2 and MT1-MMP for myotube formation.
Discussion
We have demonstrated in this study that inactivating mutations in both MMP-2 and MT1-MMP genes are synthetically lethal in the mouse. A simple model to explain the functional relationship between these two enzymes is proposed in Figure 8a 
MT
À mice). Another important implication from this study is that MMP-9, which shares similar substrate specificity with MMP-2 in vitro (Werb, 1997; Vu and Werb, 2000) , fails to compensate the M2 À
À mutations. This may be attributed to the different levels of regulation, such as tissue distribution, spatiotemporal pattern of proenzyme activation, association with other molecules, etc.
The vascular phenotypes found in the M2 À MT À mice suggest that MMP-2 and MT1-MMP are essential for À MT À mice may be explained by physical constraints or persistent intracellular signaling resulting from inappropriately accumulated ECM. Decreased release of angiogenic cytokines trapped in the ECM (Vu and Werb, 2000) , due to the decreased MMP activity, may also contribute to the phenotypes. In any event, the earlier proposal that MMPs play essential roles in flowmediated arterial enlargement (Karwowski et al., 1999; Tronc et al., 2000; de Kleijn et al., 2001; Sho et al., 2002) is consistent with our findings.
Our findings with cultured cells suggest that the M2 À MT À mutations may have a direct impact, besides the anticipated indirect effects through vascular defects, on muscle maturation. In support of this finding, several earlier reports have implicated ECM and MMP activity (although molecular species was not defined) in efficient myoblast fusion and migration (Podleski et al., 1979; Couch and Strittmatter, 1983; Fahime et al., 2000) . Whatever the cellular mechanism, one puzzling finding in light of the above model (Figure 8a ) is that overexpression of two MMPs together in C2C12 cells augmented myotube formation, while overexpression of MMP-2 alone or MT1-MMP alone suppressed myotube formation (Figure 7 ). These data seem to suggest that MMP-2 and MT1-MMP play complementary, rather than overlapping, roles in myotube formation. A variant of the model to explain myotube formation is proposed in Figure 8b . Two distinct levels ('Level 1' and 'Level 2') of MMP cascades and two parallel pathways that promote myotube formation ('P1' triggered by MMP-2 and 'P2' triggered by another protease Y of Level 2) are postulated in this model. The model also postulates that the 'Level 1' enzyme, MT1-MMP, activates two 'Level 2' enzymes, pro-MMP-2 and pro-Y, while the 'Level 2' proenzyme, pro-MMP-2, is activated by two 'Level 1' enzymes, MT1-MMP and X. If either MMP-2 or MT1-MMP is removed, one of the two parallel pathways (P1 or P2) still remains intact. When both MMP-2 and MT1-MMP are inactivated, both pathways (P1 and P2) are disrupted. These predictions are consistent with the phenotypes of the mutant mice. The assumption that MMP-2 and MT1-MMP act in different levels in the cascade is consistent with the observed cooperative effects between the two enzymes in the C2C12 system (Figure 7) . The suppressive effects of each enzyme in this system can be explained by assuming that they also have negative effects on myotube formation (N1 and N2) that become obvious when they are overexpressed individually, and that myotube promoting activity (due to the enhanced P2 pathway) prevails only when two enzymes are overexpressed in balance. Further studies are needed to test this model. Mice in which one or both of these genes are conditionally activated or inactivated may also help understanding the roles of these enzymes in vivo.
Mutations in the ryanodine receptor (RyR) gene and of the beta myosin heavy chain (MYH7) gene have been implicated in certain types of CCD (Fananapazir et al., 1993; Tubridy et al., 2001) . Our results suggest that impaired MMP activities can also lead to a CCD-like phenotype. Why these diverse mutations give rise to a common phenotype is an interesting question that remains to be addressed. Accumulating evidence indicates that disruption of the dystroglycan complex, a molecular link between the ECM and cytoskeleton, leads to another groups of disorders, muscular dystrophies, which involves muscle degeneration (Durbeej et al., 1998) . Interestingly, aberrant processing of the laminin a2 chain and increased activity of MMP-2/MT1-MMP were observed in cultured myoblasts taken from patients with congenital muscular dystrophy (Lattanzi et al., 2000) . Thus, proper levels of MMP-2/MT1-MMP activities seem to be essential for both generation and maintenance of fully functional muscle fibers.
Our findings are consistent with the hypothesis that the M2
À
MT
À mice have skeletal muscle weakness, which leads to the respiratory failure, cyanosis, and subsequent death. Further investigation is needed, however, to exactly determine the direct cause of death and the site and timing of the initial problem that leads to this end. Nevertheless, our data have clearly demonstrated the importance of MMP family members and unexpected functional overlap between the two structurally distinct members of the family, MMP-2 and MT1-MMP, in mouse development. These data also suggest the potential hazard of MMP inhibitors for fetal development and hence the need for the caution in using these drugs for pregnant women. Also, when targeting particular MMP family members in cancer treatment, drugs inhibiting both MT1-MMP and MMP-2 may be more effective than drugs inhibiting the individual enzymes. Finally, further investigation of the M2 À MT À mice may yield fresh insights into the molecular mechanisms of angiogenesis, myogenesis, and CCD.
Materials and methods
Generation and genotyping of mutant mice
The generation and genotyping of MMP-2 À/À mice have been described elsewhere (Itoh et al., 1997) . MT1-MMP À/À mice were generated by replacing exon 1 through exon 5 of the 
Histological analyses
Sections of paraformaldehyde-fixed, paraffin-embedded neonates were prepared and stained as described elsewhere (Oh et al., 2001) . The primary antibodies used for immunostaining (visualized in brown color) were CD31 (PharMingen, #01951), collagen IV (Progen, #10760), laminin (Progen, #10765), and desmin (Dako, M0760). For NADH-TR detection, new born mice were sagittally cut into halves, embedded in Tissue-Tek OCT compound (Miles), frozen in isopentane cooled in liquid nitrogen, sliced (10 mm thick) using cryostat, and stained for NADH-TR following standard protocols (Felipe, 1983) (visualized in dark purple color). Morphometric analyses of blood vessels were carried out using the software NIH Image. Transmission electron microscopy was carried out as described elsewhere (Oh et al., 2001) .
Cell culture
For semiquantitative analysis of the myogenic potential of whole embryonic cells in culture, E10.5. embryos were broken into 20-30 pieces by mild pipetting in 2 ml PBS, and the tissue pieces were collected by brief centrifugation, resuspended in 0.5 ml a-MEM containing 40% fetal calf serum plus antibiotics, and plated onto a collagen-coated 35 mm dish (IWAKI). After overnight incubation, the cells were fed with 1.5 ml medium and the incubation was continued up to 21 days with medium change (2 ml) once every 3 or 4 days. C2C12 murine myoblast cells were maintained in DMEM containing 15% fetal bovine serum. Cotransfection of C2C12 cells with the pcDNA3.1( þ )/hygro vector (Clontech) containing mouse MMP-2 cDNA (Reponen et al., 1992) and/or the pCXN2neo vector (Niwa et al., 1991) containing human MT1-MMP cDNA (Sato et al., 1994) was performed by the standard calcium phosphate method, followed by selection with 400 mg/ ml hygromycin B plus 1 mg/ml G418. Myotube formation was induced by incubating the cells (5 Â 10 4 per 35 mm dish) in DMEM containing 2% horse serum (differentiation medium). Numerical data were analysed by student's t-test using SigmaPlot software.
